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Abstract The α-humulene synthase from Zingiber zerumbet Smith was expressed as a
polyhistidine-tagged protein in an E. coli BL21(DE3) strain. Induction time and inductor
(isopropyl-β-D-thiogalactopyranoside) concentration were optimized. The enzyme was suc-
cessfully purified directly from cell lysate by NTA affinity column chromatography and
careful selection of coordinated metal ion and imidazole elution conditions. Bioactivity assays
were conducted with the natural substrate farnesyl diphosphate (FDP) in a two-phase system
with in situ extraction of products. The conversion of FDP to α-humulene (~94.5 %) and β-
caryophyllene (~5.5 %) could be monitored by gas chromatography-flame ionization detection
(GC-FID). Optimal pH and temperature as well as kinetic parameters KM and kcat were
determined using a discontinuous kinetic assay.
Keywords Terpene synthase . Sesquiterpene . Humulene . Recombinant expression .
Purification . Enzyme activity
Introduction
Natural products continue to be the most important source of lead compounds for the
pharmaceutical industry since the past century [1]. Many natural products have been
successfully developed for the clinical use to treat human diseases in a wide range of
therapeutic areas [2]. Although synthetic chemistry has also produced many new
bioactive substances and combinatorial techniques have considerably expanded the
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number of compounds available for tests, natural products and their derivatives
represent over 50 % of drugs in clinical use [3].
With over 30,000 characterized substances, terpenes are the largest and most structurally
diverse class of natural products. Terpenes are widely distributed in nature occurring in plants,
bacteria, fungi, and marine organisms. However, most of the isolated and identified terpene
structures are of herbal origin. As primarymetabolites, they are essential for plant survival, having
functions in, e.g., respiratory system, in photosynthesis, and in regulation of plant growth [4–7]. A
majority of terpenes are compounds of the secondary metabolism, playing an important role, e.g.,
in defense and protection mechanisms [8] or in plant volatile communication [9].
Despite their extensive application in industrial sector as flavors and fragrances in food as
well as in perfumery and cosmetic products, many terpenes have biological activities and are
used for the treatment of human diseases. The worldwide sales of terpene-based pharmaceu-
ticals in 2002 were approximately US$12 billion [10]. More and more terpenes have been
discovered as effective compounds in human disease therapy and prevention, presumably
leading to an increasingly important role of terpenoids as medical drugs.
The sesquiterpenoid zerumbone is a highly potential pharmaceutical agent. It was first
isolated from the rhizome of tropical wild shampoo ginger (Zingiber zerumbet Smith) [11].
Presently, zerumbone has been extensively studied for its effectiveness in a broad range of
biological activities including antimicrobial [12], antioxidant [13], antidiabetic [14], antitumor
[15], anti-inflammatory [16], antiangiogenic [17] and antiallergic properties [18].
The biosynthesis of zerumbone in Z. zerumbet Smith from the sesquiterpene precursor farnesyl
diphosphate (FDP) is analogous to other known plant sesquiterpene ketones [19, 20] (Fig. 1). In the
initial step, the reaction of FDP is catalyzed byα-humulene synthase (HUM) givingα-humulene as
the major product (95 %) and β-caryophyllene as the minor product (5 %) [11]. In a subsequent
reaction by α-humulene-8-hydroxylase, α-humulene is converted to 8-hydroxy-α-humulene [21]
which is finally oxidized by the dehydrogenase zerumbone synthase to yield zerumbone [22].
α-Humulene synthase is a key enzyme in zerumbone biosynthesis. Althoughα-humulene is a
common sesquiterpene widely distributed in plants, the synthase from Z. zerumbet Smith is the
only known sesquiterpene synthase catalyzing the formation of α-humulene as major product.
In this work, we describe the heterologous expression and purification of α-humulene
synthase from Z. zerumbet Smith in E. coli. Although the sesquiterpene synthase was
Fig. 1 Proposed mechanism of zerumbone biosynthesis in Z. zerumbet Smith. Products of the catalyzed reaction
of α-humulene synthase are highlighted
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published previously [11], no characterization of key enzymatic properties was described to
date. Herein we present a characterization of recombinant α-humulene synthase in terms of
temperature and pH optimum, pI, and the first ever determined enzyme kinetic data.
Materials and Methods
Cloning of Expression Construct
The complementary DNA (cDNA) sequence GenBank: AB247331 [11] was carefully codon-
optimized for expression in E. coliK12 derivative strains using a guided-random approach [23].
The optimized sequence (1684 bp) was ordered as two individual double stranded DNA
fragments of 684 bp and 1000 bp length using the GeneArt© Strings™ service (Life
Technologies, USA). For fast and seamless cloning, the proprietary GeneArt© Seamless cloning
& assembly system (Life Technologies, USA) was used, which exploits overlapping fragments
created by PCR to ligate seamless constructs without restriction enzyme digestion. Primers were
designed to create a 15-bp overlap of the inserts and vectors after amplification (Table 1).
To yield long and error-free PCR products, the circular vector pET16b (Life Technologies,
USA) as well as both synthetic DNA strings were amplified using Q5® High-Fidelity DNA
Polymerase (NEB, USA). Typical PCR reactions consisted of 10 μl 5× Q5 HF buffer, 1 μl
dNTP mix (10 mM each), 2.5 μl respective forward and reverse primer (10 μM each), 1 μl
cDNA template, and 0.5 μl Q5 DNA polymerase in a total volume of 50 μl (add H2O). PCR
reactions were performed at 98 °C for 10 s for initial denaturation, 15 cycles at 98 °C for 10 s,
72–62 °C for 30 s (Touchdown PCR annealing step), and 72 °C for 1 min. Following the initial
touchdown PCR cycles, additional 20 cycles consisting of denaturation at 98 °C for 10 s,
annealing at 62 °C for 30 s, elongation at 72 °C for 1 min, and a final elongation at 72 °C for
10 min were conducted. Elongation time was raised up to 3 min and 20 s for PCR of the vector
fragment. PCR conditions and annealing temperatures were adapted depending on primers and
templates used in the reaction. PCR reactions using plasmid DNA as template were digested
with DpnI (NEB, USA) for 1 h at 37 °C to lower background after transformation. Fragment
sizes were verified by analytical agarose gels, and the products were purified using QIAquick
PCR Purification Kit (QIAGEN GmbH, Germany). Assembly reactions were conducted
following manufacturer recommendations, and 8 μl of the fused construct were chemically
transformed in competent E. coli TOP10 cells (Life Technologies, USA). Plasmid DNA of
positive clones was purified, sequenced, and transformed into E. coli BL21(DE3) cells (Merck
Millipore, Germany) for expression studies.
Table 1 Primers designed for use in seamless assembly reaction of the optimized hum gene
Description Primer sequence (5′-3′)
pET16b_Vector_FWD CATATGCTCGAGGATCCG
pET16b_Vector_REV ACGACCTTCGATATGGCC
Hum_opt_Str1_FWD CATATCGAAGGTCGTGAGCGACAATCGATGGCGCT
Hum_opt_Str1_REV GGAACACAGTCGACCGCCTGCGGTTCCCACCGCTC
Hum_opt_Str2_FWD GTGGGAACCGCAGGCGGTCGACTGTGTTCCCGAAT
Hum_opt_Str2_REV ATCCTCGAGCATATGTTAGATCAAGAAAGATTCCA
3
Expression of Sesquiterpene Synthase in E. coli
The expression of terpene synthase gene in E. coli was carried out in TB (terrific broth)
medium (12 g·l−1 tryptone, 24 g·l−1 yeast extract, 4 ml·l−1 glycerol, 10 ml·l−1 potassium
phosphate buffer) and SB (super broth) medium (32 g·l−1 tryptone, 24 g·l−1 yeast extract, 5 g·
l−1 NaCl, 5 ml·l−1 NaOH (1 N)). Precultures were set up in 25 ml of LB-Miller medium
supplemented with carbenicillin (100 μg·ml−1). The medium was inoculated with glycerol
stocks of cells and incubated overnight at 37 °C and 150 rpm in an orbital shaker. Main
cultures in TB or SB medium containing the same concentration of antibiotics were inoculated
with preculture to give an initial optical density of OD600 0.1 rel. AU and grown under the
same conditions as above to specify absorbance values at 600 nm. Gene expression was
induced by adding isopropyl-β-D-thiogalactopyranoside (IPTG) at a specific final concentra-
tion, and growth was continued at 20 °C and 150 rpm for 24 h post induction. Culture samples
were normalized according to their optical density at 600 nm to monitor recombinant protein
production by SDS-PAGE. After centrifugation (4000×g, 4 °C, 15 min), cell pellets were
resuspended in extraction buffer (50 mMMOPS pH 7.0, 5 mMMgCl2, 5 mMDTT, 10 % (v/v)
glycerol) and sonicated during 6×15 s time intervals (0.6 s cycle, 100 % amplitude) while the
cell suspension was kept on ice to prevent heating-up. Cell extracts were centrifuged
(14,000×g, 4 °C, 45 min), and the supernatant containing the total soluble protein extract
was collected. Insoluble protein pellets were suspended in lysis buffer (100 mM potassium
phosphate pH 7.0, 10 mM sodium metabisulfite, 10 mM β-mercaptoethanol, 10 mM ascorbic
acid, 6 M urea) and solubilized by shaking at 30 °C for 1 h. Samples were directly applied in
SDS-PAGE analysis (5 % stacking gel, 10 % separation gel). Gels were stained by colloidal
coomassie staining. PageRuler Prestained Protein Ladder #26616 and Pierce Unstained Protein
MW Marker #26610 (both Thermo Scientific, USA) were used as molecular weight markers.
Bioreactor Cultivation
Bioreactor cultivations were carried out at 20 °C in a 2-L bioreactor (Biostat B, B. Braun
Biotech, Melsungen, Germany). SB medium was used as production medium in 1.8 l working
volume. Foam production was controlled by the addition of antifoam. The pH value was
maintained at pH 7 by adding 1 M sodium hydroxide solution. The concentration of dissolved
oxygen was kept constantly at 20 % air saturation by adjusting the stirrer speed (0–1700 rpm)
at an aeration rate of 1 vvm.
The starter culture was prepared by inoculating a glycerol stock into 25 ml LB medium and
subsequently incubating at 37 °C, 150 rpm for 10 h. The culture was diluted up to an OD600 of
0.1 rel. AU in 100 ml SB medium and grown for further 10 h at 37 °C, 150 rpm. The reactor
was inoculated with preculture to give an initial OD600 of 0.1 rel. AU. Cultivations in a
bioreactor were carried out at 37 °C. After IPTG addition, temperature was lowered to 20 °C.
Cells were sampled at different times to monitor biomass and recombinant protein production.
Purification of Recombinant Sesquiterpene Synthase
Biomass was harvested after 24 h post induction by centrifugation (4000×g, 4 °C, 15 min) and
resuspended in IMAC binding buffer (50 mMMOPS pH 7.5, 500 mM NaCl, 10 mM MgCl2,
50 mM imidazole, 10 % (v/v) glycerol) to give a concentration of 100 mg wet cell-mass per
milliliter. The cell suspension was sonicated during 10×15 s time intervals (0.6 s cycle, 100 %
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amplitude) on ice. After centrifugation (4000×g, 4 °C, 60 min), the supernatant was filtered
using 0.2-μm syringe filters. The recombinant sesquiterpene synthase was purified from protein
extract using an HiTrapTM IMAC FF 5 ml affinity column (GE Healthcare, USA), decorated
with specific divalent cations (Cu2+, Ni2+, Co2+, Zn2+) on a BioLogic DuoFlow FPLC system
(Bio-Rad Laboratories Inc., USA). Preparation of columns with different cations was per-
formed following manufacturer’s instructions. After binding to the column matrix, unbound
protein was washed off with binding buffer. The subsequent elution of the target protein was
carried out with IMAC elution buffer (50 mM MOPS pH 7.5, 500 mM NaCl, 10 mMMgCl2,
500 mM imidazole, 10 % (v/v) glycerol). Eluted fractions were concentrated using a Vivaspin
20 ultrafiltration unit with a molecular weight cut-off (MWCO) of 10 kDa (Sartorius-Stedim
Biotech, Germany), followed by a buffer exchange to a storage buffer (50 mMMOPS pH 7.0,
15mMMgCl2, 5 mM sodium ascorbate, 5 mMDTT, 10% (v/v) glycerol) in three ultrafiltration
steps. Aliquots of 100 μl enzyme solution were stored at −20 °C.
Homogeneity of the recombinant enzyme product was analyzed by SDS-PAGE and
Western blots after purification. Enzyme purity was determined by densitometry of colloidal
coomassie-stained SDS-PAGE gels. Western blots were performed after semi-dry plotting on
PVDF membrane, using 6x-His epitope tag mouse antibody #MA1-21315 (Thermo Scientific,
USA) as primary and goat anti-mouse HRP conjugate #401215 (Calbiochem, USA) as
secondary antibody. Blots were stained using 3,3′,5,5′-Tetramethylbenzidine (TMB) as sub-
strate. Quantification was done by measuring adsorption at 280 nm (theoretical MW 64.5 kDa,
extinction coefficient 90,190 M−1 cm−1) with Nano-Drop 1000 UV-vis spectrophotometer
(Thermo Scientific, USA).
Biotransformation Assay and GC-FID Analysis of Sesquiterpenes
A single-vial assay method for bioactivity testing of sesquiterpene synthases was adapted.
Bioactivity assay of the purified sesquiterpene synthase was conducted using 1.6 μg of protein
in a total reaction volume of 500 μl activity buffer (50 mM MOPS pH 7.0, 15 mM MgCl2,
5 mM sodium ascorbate, 5 mM DTT) containing 30 μM FDP tris-ammonium salt (Mobitec,
Germany). Assay mixture was overlaid with 200 μl iso-octane and incubated for 15 min at
38 °C. Terpene products were extracted by vigorous shaking for 30 s. The organic phase was
removed after centrifugation and analyzed by GC-FID.
Identification of Enzyme Kinetic Parameters
Kinetic analysis of the recombinant enzyme was conducted using a discontinuous kinetic
assay. Master mixes consisting of activity buffer (50 mM MOPS pH 7.0, 15 mM MgCl2,
5 mM sodium ascorbate, 5 mM DTT) and FDP tris-ammonium salt at certain varying
concentrations (1, 5, 10, 20, 30, 50, 80, 10 μM) were prepared for each assay run to yield a
total volume of 2.8 ml. The reaction was initiated by the addition of 0.05 μM (final
concentration) recombinant sesquiterpene synthase to a total reaction volume of 2.8 ml. The
assay mix was immediately splitted into five separate reaction tubes (500 μl reaction volume
each), overlaid with 200 μl iso-octane, and incubated in a water bath at 38 °C. The linear
reaction was terminated at certain time intervals (0.5, 1, 2, 3, 4 min) by intensive shaking for
30 s. Phases were separated by short centrifugation, and the organic layer was transferred to a
GC vial for further GC-FID analysis. The initial reaction slope for each sample was determined
by linear regression. Kinetic constants of the recombinant sesquiterpene synthase were
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determined by fitting the data to the Michaelis-Menten model by non-linear regression using
GraphPad Prism software (GraphPad Software Inc., USA). Data presented represent the means
of at least two determinations.
A calibration curve using commercially available α-humulene (Sigma-Aldrich, Germany)
was generated for the purpose of quantifying sesquiterpenes. α-Humulene standards were
made in iso-octane at concentrations of 0.05, 0.5, 1, 2.5, 5, and 10 μg·ml−1. Samples were
measured by the aforementioned GC-FID method. A calibration curve was generated by
plotting the average peak area of each sample against its concentration.
Determination of Optimal Temperature and pH
Optimal temperature and pH of the recombinant terpene synthase were determined by the
above mentioned discontinuous kinetic assay method at various designed temperatures (34, 36,
38, 40, 42, 44 °C) and pH (pH 6, 6.5, 7, 7.5, 8, 8.5, 9), respectively. Samples were analyzed by
GC-FID, and initial reaction slopes were plotted to the temperature or pH. Data presented
represent the means of at least two determinations.
Results and Discussion
Soluble Expression in E. coli and Optimization of Expression Conditions
Induction Time
A parametric study was conducted to optimize the induction conditions in the production of
recombinant α-humulene synthase in the overexpressing strain of E. coli BL21(DE3) in shake-
flask cultures. In the plasmid pET16b::his-FXa-hum, the α-humulene synthase gene (hum) is
under the control of the lac promoter. IPTG was used to induce the lac promoter for the
synthesis of α-humulene synthase.
The growth behavior of recombinant E. coli BL21(DE3) cells containing the codon-
optimized hum overexpressing plasmid pET16b::his-FXa-hum was investigated. The culture
was inoculated to an initial OD600 of 0.1 rel. AU and cultivated at 37 °C in standard TB
medium. The growth curve is shown in Fig. 2.
The exponential phase was completed within a time course of 12 h after which the cells
entered the stationary phase. Higher cell concentrations may reduce production of recombinant
Fig. 2 Growth curve of E. coli
BL21(DE3)/pET16b::his-FXa-hum
cells at 37 °C in TB medium
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protein, as nutrient limitation may occur. According to Eriksen et al., an increase in solubility of
recombinant protein is observed when expression is induced in early-exponential phase [24].
Hence, induction of cells was investigated in lag to mid-exponential phase. In order to determine
the time course of induction, five shake-flask fermentations were performed in parallel. Main
cultures in TBmedium were inoculated to an initial OD600 of 0.1 rel. AU and grown at 37 °C to
an OD600 of 0.1, 0.5, 1.0, 3.0 or 4.0 rel. AU, and then induced with 0.1 mM IPTG (final
concentration). After addition of the inducer to the cultivation broth, growth temperature was
lowered to 20 °C to improve protein solubility. Incubation of flasks was continued for 24 h.
Samples were taken directly before IPTG addition and at the end of cultivation time after 24 h to
analyze protein production by SDS-PAGE. The amounts of recombinant enzyme produced by
varying induction time were determined by gel densitometry after sonication. SDS-PAGE gels
of soluble and insoluble cell fractions are shown in Fig. 3a, b.
The highest enzyme yield of ~3.20 μg·mg−1 WCW in cell extracts was found to be attained
when expression was induced at an OD600 of 1.0 rel. AU. However, SDS-PAGE analysis of
insoluble cell fractions shows an increase in recombinant enzyme production when inducing at
lower cell densities. It can be suggested that the recombinant sesquiterpene synthase is
produced more actively in cells at an early stage of growth and therefore tends to form
inclusion bodies in order to minimize toxic effects for the cells. As it is important to obtain
HUM in its soluble form, an OD600 of 1.0 rel. AU was determined to be the optimum time
point for induction for further experiments.
Inductor Concentration
After determining the optimal induction time, the effect of the inducer concentration on the
efficiency of the induction was examined by using 0.025, 0.05, 0.1, 0.15, and 0.2 mM IPTG
concentrations. Five parallel shake-flask cultivation fermentations were performed in TB
medium, and all cultures were inoculated to an initial OD600 of 0.1 rel. AU. All cultures were
grown to an OD600 of 1.0 at 37 °C and subsequently IPTG was added to each culture flask to
induce expression. Cultures were incubated at 20 °C for further 24 h. Again, samples were taken
directly before IPTG addition and at the end of cultivation time after 24 h. Cell extracts as well
as insoluble cell fractions obtained after sonication were analyzed by SDS-PAGE (Fig. 4a, b).
The protein gels show that an increase in IPTG concentrations resulted in a higher HUM
production. Although the amount of recombinant protein produced in the cells steadily increases,
most of the protein is found to aggregate in inclusion bodies. An increase of IPTG concentration
from 0.1 to 0.2 mM did not result in any significant improvement in soluble protein production.
Densitometric analysis of the cell extracts shows that the highest yield of soluble recombinant
HUM with ~3.35 μg·mg−1 WCW is obtained when inducing expression with 0.15 mM IPTG.
Medium Optimization
To ensure sufficient nutrient supply, the cultivation medium was further enhanced by
providing threefold concentration of tryptone (SB medium) during the subsequent opti-
mization steps to adapt cultivation process to bioreactor. Densitometric SDS-PAGE anal-
ysis of soluble cell extracts and insoluble cell fractions showed a higher recombinant
protein production (~13 %) in SB medium than in TB medium (Fig. 5). Besides, cultiva-
tions in SB medium yielded in a higher biomass production. Densitometric analysis
showed a soluble/insoluble protein ratio of 40:60 %.
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Bioreactor Cultivation
The conditions set up at flask level were scaled up at 2 l batch bioreactor scale. When cells
reached an optical density of OD600=1.0 rel. AU (as indicated by the arrow in Fig. 6), HUM
production was induced by adding 0.15 mM IPTG to the reactor, and temperature was
decreased from 37 to 20 °C.
HUM production increased consistently until 9 h after induction. Beyond that point, a
decrease in HUM concentration was observed. The rapid degradation of HUM indicates
Fig. 3 SDS-PAGE gels of recombinant α-humulene synthase production in E. coli BL21(DE3) cells in
dependency of induction time point. Gels showing expression of codon-optimized hum gene in both soluble
(a) and insoluble (b) fractions. Samples were normalized based on OD600. M marker, t0 sample before induction
with IPTG, t1 sample 24 h after induction and expression at 20 °C
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that nutrient deficiency presumably a depletion of one or more essential amino acids
occurred. Total consumption of a certain amino acid may lead to changes in metabolic
flow, protein synthesis, and possibly also leads to short-time stringent response before
the cell induces the set of enzymes for synthesis of this amino acid. Degradation of the
recombinant protein provides amino acids for the synthesis of essential proteins. Final
HUM production level reached 140 mg·l−1 in comparison to 156 mg·l−1 at the highest
point of production. Therefore, cells should be harvested before nutrient deficiency
occurs.
Fig. 4 SDS-PAGE gels of recombinant α-humulene synthase production in E. coli BL21(DE3) cells in
dependency of inductor concentration. Gels showing expression of codon-optimized hum gene in both soluble
(a) and insoluble (b) fractions. Samples were normalized based on OD600. M marker, t0 sample before induction
with IPTG, t1 sample 24 h after induction and expression at 20 °C
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Purification of Recombinant α-Humulene Synthase
After cell disruption and centrifugation, recombinant α-humulene synthase was purified from
cell extracts by immobilized metal ion chromatography (IMAC) using NTA ligands. For optimal
purification conditions, four different cations, namely Cu2+, Ni2+, Co2+, and Zn2+, that coordi-
nated to NTA on matrix surface were analyzed regarding purification efficiency and product
Fig. 5 Comparison of recombinant α-humulene synthase production in E. coli BL21(DE3) cells in TB and SB
medium. SDS-PAGE gels showing expression of codon-optimized hum gene in both soluble (a) and insoluble (b)
fractions. Samples were normalized based on OD600.M marker, t0 sample before induction with IPTG, t1 sample
24 h after induction and expression at 20 °C
Fig. 6 IPTG induced production of recombinant α-humulene synthase during batch cultivation of E. coli
BL21(DE3)/pET16b::his-FXa-hum. HUM concentrations in the reactor were estimated by gel densitometry.
Time point of induction with 0.15 mM IPTG is indicated by a dashed line
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recovery. To reduce non-specific binding of endogenous E. coli proteins onto the matrix surface,
10 mM imidazole was added to the binding buffer. After washing off unbound protein, the
recombinant enzyme was eluted with 500 mM imidazole in buffer. Eluted fractions containing
the protein of interest were pooled, fused, and dialyzed by ultrafiltration with Sartobind
ultrafiltration units (MWCO 10 kDa). Buffer exchange against activity buffer containing Mg2+
ions was performed in three subsequent steps resulting in an imidazole dilution of 1:9000.
Fractions containing protein were kept cooled during the whole purification process to prevent
protein degradation and inactivation. The purification efficiency using different metal ions was
compared by SDS-PAGE analysis with sensitive silver-staining (Fig. 7).
Flow-through fractions showed no unbound HUM leading to the assumption that the his-
tagged recombinant enzyme was bound efficiently to NTA ligands irrespective of the coordi-
nated metal ion. However, eluted fractions show significant differences in purity. Coordinating
Cu2+ ions to the NTA ligands resulted in a high non-specific binding of endogenous host cell
proteins due to the high affinity of Cu2+ to histidine groups. Zn2+-IMAC showed much less
impurities in eluted protein fractions which is consistent with the fact that Zn2+ ions are less
affine to histidine groups. However, the recovery rate of 80 % of the protein of interest using
Zn2+ ions is the lowest compared to all other metal ions tested. Ni2+- and Co2+-IMAC seemed to
be similar in product purity (60 and 63%) and recovery (93 and 95%). As Co2+-IMAC showed
the best purity to recovery ratio, further purification experiments were done using Co2+-IMAC.
To enhance product purity, Co2+-IMAC was conducted using an imidazole gradient up to
500 mM imidazole (data not shown). An imidazole concentration of 50 mMwas determined to
be suitable to remove most of the host cell proteins bound to the matrix. Therefore, purification
of the his-tagged synthase was done by a two-step elution, the first step with imidazole
concentrations of 50 mM and the second step with 500 mM imidazole to elute the protein
of interest (Fig. 8a, b). Enzyme recovery was ~67 %, whereas enzyme purity was
densitometrically determined to be >92 %.
Western blot was prepared using a rather non-specific anti-his antibody as there is no known
specific antibody for the enzyme. Western blot showed that the his-tagged enzyme could be
successfully isolated from cell extracts (Fig. 9a). To determine the isoelectric point, a 2D gel
electrophoresis was conducted including an isoelectric focusing step in the range of pH 3–10
Fig. 7 Metal affinity chromatography using Cu2+, Ni2+, Co2+, and Zn2+. M marker, CE cell extract of E. coli
BL21(DE3)/pET16b::his-FXa-hum before being loaded on IMAC column, FT flow-through fractions, EF pooled
eluted fractions, UF concentrated protein after ultrafiltration
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(Fig. 9b). The native pI was determined to be ~5.61 for the his-tagged protein which nearly
matches the calculated pI of 5.65 and is comparable to other sesquiterpene synthases [25, 26].
Bioactivity Assay and Effect of Temperature and pH on Terpene Synthase Activity
To assess the product spectrum of the recombinant HUM, bioactivity assays with the natural
substrate farnesyl diphosphate were performed in a 500-μl scale in a two-phase system with an
aqueous reaction solution containing activity buffer, enzyme and substrate, and an organic
Fig. 8 Metal affinity chromatography of clarified cell lysate using Co2+ (a). Elution was carried out with a
two-step elution with imidazole. SDS-PAGE gel (b) shows collected FPLC fractions.Mmarker, CL cell lysate of
E. coli BL21(DE3)/pET16b::his-FXa-hum before being loaded on IMAC column, FT1–2 flow-through fractions,
EF1–4 eluted fractions, EF5 pooled and concentrated eluted fraction
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solvent overlay of 200 μl iso-octane. Reactions were terminated by vigorous shaking, resulting
in enzyme degradation and product extraction to the organic phase. The organic phase was
separated and analyzed by GC-FID.
Chromatograms showed two product peaks with a ratio of ~94.5:5.5 % (Fig. 10). By
comparison to commercially available standards, the major product could be identified as α-
humulene and the minor product of the recombinant enzyme as β-caryophyllene.
Characterization of enzyme activity in dependence of temperature and pH was carried out
by analyzing reaction rates at various temperatures (34–44 °C) and pH (pH 6–9) (Fig. 11a, b).
Reactions were carried out in the aforementioned two-phase system. Studies of the recombi-
nant terpene synthase showed an optimal activity at 38 °C. Testing the synthase activity at
different pH showed optimum activity at pH 7.5. In previously published data, temperature and
pH optimum for sesquiterpene synthases are reported to lie in a range of 20–40 °C [25] and
pH 6.0–7.0, respectively [26], which is consistent with the results obtained in this work.
Kinetic properties were measured using FDP as a substrate with above determined optimal
reaction conditions in a range of 1 to 100 μM. Measuring of product concentrations trapped in
the organic layer was done by peak integration using GC-FID, based on an α-humulene
calibration curve. An enzyme concentration of 0.05 μM was found to be suitable in prelim-
inary tests to obtain initial reaction rates in a linear range. The data were fitted to an assumed
Michaelis-Menten model using non-linear curve fitting (Fig. 12).
Michaelis-Menten constant KM and maximum reaction rate vmax were calculated for α-
humulene as a single product (KM=33.07 μM, vmax=0.19 μM·s
−1, kcat=3.80 s
−1) and the total
product spectrum (KM=32.79μM, vmax=0.20 μM·s
−1, kcat=3.91 s
−1). The relatively lowKM value
signifies a high binding affinity of HUM to its substrate FDP. In comparison to other sesquiterpene
synthases, the Michaelis-Menten constant of HUM mostly ranks higher, e.g., the sesquiterpene
Fig. 9 Western blot of cell lysate of E. coli BL21(DE3)/pET16b::his-FXa-hum and purified HUM (a). 2D gel
electrophoresis of purified HUM (b)
Fig. 10 GC-FID chromatogram
showing analyzed organic phase
with conversion products
α-humulene (1) and
β-caryophyllene (2) of
recombinant HUM
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synthase (+)-germacrene D synthase (KM=2.5 μM) [27] which shows a high sequence similarity
(identity>63 %) has a KM value that is about 13 times lower. However, it is reported that enzymes
binding to substrates with a molecular weight above 350 g·mol−1 show an average KM value of
approximately 40 μM [28]. Also, similar KM values are observed within the whole class of terpene
synthases [29, 30]. The maximum reaction rate vmax 0.20 μM·s
−1 and the derived turnover number
kcat 3.91 s
−1 are rather high compared tomany other described sesquiterpene synthases. Considering
the relatively simple reaction catalyzed (just one cyclization reaction) compared to terpene synthases
with a broad or complex product spectrum [25, 31], this result could be explainable. Also, the
turnover number of the HUM lies in the typical range of enzymes of the secondarymetabolism [25]
and is not uncommon between sesquiterpene synthases [32, 33].
Fig. 11 Relative activity of
recombinant HUM in dependence
of pH (a) and temperature (b).
Initial rate of reaction was plotted
against increasing pH and
temperature, respectively. Each
data point represents at least two
individual linear regression plots
with product concentrations
determined at five time points
Fig. 12 Michaelis-Menten fitted plot. Initial rate of reaction was plotted against increasing substrate concentra-
tions. Each data point represents at least two individual linear regression plots with product concentrations
determined at five time points
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Conclusion
We have successfully expressed, purified, and biochemically characterized the sesquiterpene
synthase α-humulene synthase from shampoo ginger (Z. zerumbet Smith) for the biocatalytic
production of α-humulene. This is the first time to report the key enzymatic properties of α-
humulene synthase. Since the synthesis of the macrocyclic sesquiterpene α-humulene is
chemically challenging, bioconversion strategies can provide an efficient route for large scale
production of sesquiterpenes. Further studies will aim at converting the major product α-
humulene in vitro to the valuable sesquiterpenoid zerumbone.
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